Simon Allan

2.7k total citations · 1 hit paper
54 papers, 2.0k citations indexed

About

Simon Allan is a scholar working on Surgery, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Simon Allan has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Oncology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Simon Allan's work include Palliative Care and End-of-Life Issues (11 papers), Nausea and vomiting management (7 papers) and Lung Cancer Research Studies (6 papers). Simon Allan is often cited by papers focused on Palliative Care and End-of-Life Issues (11 papers), Nausea and vomiting management (7 papers) and Lung Cancer Research Studies (6 papers). Simon Allan collaborates with scholars based in United Kingdom, New Zealand and Australia. Simon Allan's co-authors include Allan Lipton, Helen Wheeler, Lester Porter, Dirk J. Reitsma, Clive Sinoff, Robert Knight, Gabriel N. Hortobágyi, Joseph F. Simeone, Douglas W. Blayney and John J. Seaman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Simon Allan

53 papers receiving 1.9k citations

Hit Papers

Efficacy of Pamidronate in Reducing Skeletal Complication... 1996 2026 2006 2016 1996 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Allan United Kingdom 19 1.1k 521 457 357 249 54 2.0k
Thomas E. Lad United States 22 1.1k 1.0× 618 1.2× 291 0.6× 160 0.4× 194 0.8× 74 1.9k
George Dranitsaris Canada 26 1.4k 1.3× 508 1.0× 499 1.1× 209 0.6× 112 0.4× 120 2.6k
Mario Di Palma France 28 971 0.9× 1.1k 2.1× 489 1.1× 352 1.0× 131 0.5× 121 2.5k
Helgi Sigvaldason Iceland 32 688 0.7× 374 0.7× 599 1.3× 158 0.4× 305 1.2× 82 3.3k
Laurent Zelek France 28 1.4k 1.4× 685 1.3× 343 0.8× 253 0.7× 247 1.0× 120 2.8k
Aruna Kamineni United States 28 1.4k 1.3× 651 1.2× 479 1.0× 98 0.3× 443 1.8× 93 2.6k
Bee‐Choo Tai Singapore 24 540 0.5× 776 1.5× 736 1.6× 110 0.3× 134 0.5× 65 2.8k
Karen K. Swenson United States 27 1.2k 1.2× 176 0.3× 416 0.9× 100 0.3× 266 1.1× 55 2.0k
Alan S. Morrison United States 30 943 0.9× 712 1.4× 668 1.5× 120 0.3× 308 1.2× 56 2.8k
Maureen P. Neary United States 25 717 0.7× 538 1.0× 362 0.8× 97 0.3× 92 0.4× 111 2.4k

Countries citing papers authored by Simon Allan

Since Specialization
Citations

This map shows the geographic impact of Simon Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Allan more than expected).

Fields of papers citing papers by Simon Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Allan. The network helps show where Simon Allan may publish in the future.

Co-authorship network of co-authors of Simon Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Allan. A scholar is included among the top collaborators of Simon Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Allan. Simon Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hayward, Louise, et al.. (2023). National qualifications in Scotland: A lightning rod for public concern about equity during the pandemic. European Journal of Education. 58(1). 83–97. 2 indexed citations
3.
Seah, Davinia, Andrew Wilcock, Sungwon Chang, et al.. (2022). Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. Palliative Medicine. 36(9). 1408–1417. 5 indexed citations
4.
Chang, Sungwon, Jane Hunt, Matthew Doogue, et al.. (2022). Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. Palliative Medicine. 36(6). 938–944. 5 indexed citations
5.
Allan, Simon, Ifedayo Adetifa, & Kaja Abbas. (2021). Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya. BMC Infectious Diseases. 21(1). 553–553. 30 indexed citations
6.
Allan, Simon, et al.. (2020). Intranasal Fentanyl Versus Placebo for Treatment of Episodic Breathlessness in Hospice Patients With Advanced Nonmalignant Diseases. Journal of Pain and Symptom Management. 61(5). 1035–1041. 4 indexed citations
7.
Siu, Wilson, et al.. (2017). PWE-074 Validation of baveno vi recommendations on avoidance of screening endoscopy in low-risk cirrhotic patients. HighWire Press Open Archive. A163.2–A163. 1 indexed citations
8.
Hatano, Yutaka, Matteo Moroni, Andrew Wilcock, et al.. (2016). Pharmacovigilance in hospice/palliative care: the net immediate and short-term effects of dexamethasone for anorexia. BMJ Supportive & Palliative Care. 6(3). 331–337. 13 indexed citations
9.
Hardy, Janet, et al.. (2016). A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease. Supportive Care in Cancer. 24(7). 3069–76. 14 indexed citations
10.
11.
Clark, Jean, et al.. (2011). Staff Perceptions of End-of-Life Care in Aged Residential Care: A New Zealand Perspective. Journal of Palliative Medicine. 14(6). 688–695. 34 indexed citations
12.
Reck, Martin, Nico van Zandwijk, Cesare Gridelli, et al.. (2010). Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study. Journal of Thoracic Oncology. 5(10). 1616–1622. 107 indexed citations
13.
Harnett, Paul R., Martin Buck, Philip Beale, et al.. (2007). Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study. International Journal of Gynecological Cancer. 17(2). 359–366. 14 indexed citations
14.
Pérez, David, et al.. (1995). The information needs of patients with breast cancer. Australian and New Zealand Journal of Medicine. 25(5). 521–522. 9 indexed citations
15.
Jameson, Michael B., B D Evans, Daniel H.D. Gray, et al.. (1995). Adjuvant chemotherapy for non‐metastatic osteosarcorna of the extremities in two New Zealand cancer centres. Australian and New Zealand Journal of Medicine. 25(3). 224–229. 2 indexed citations
16.
Ma, Lingjun, et al.. (1992). Case-Control Study of Factors Associated With Failure to Detect Breast Cancer by Mammography. JNCI Journal of the National Cancer Institute. 84(10). 781–785. 178 indexed citations
17.
Allan, Simon, Susan Evans, James Cassidy, et al.. (1991). Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacology. Cancer Chemotherapy and Pharmacology. 28(1). 55–58. 13 indexed citations
18.
Allan, Simon, et al.. (1990). Prognosis at presentation of small cell carcinoma of the lung. European Journal of Cancer and Clinical Oncology. 26(6). 703–705. 30 indexed citations
19.
Allan, Simon. (1987). Mechanisms and management of chemotherapy-induced nausea and vomiting. Blood Reviews. 1(1). 50–57. 14 indexed citations
20.
Allan, Simon, M A Cornbleet, James Carmichael, S.J. Arnott, & John F. Smyth. (1986). Adult neuroblastoma report of three cases and review of the literature. Cancer. 57(12). 2419–2421. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026